June 16, 2023 June 16, 2023Categories Press ReleasesMedia Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials
June 1, 2023 June 1, 2023Categories Press ReleasesPress Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials
May 31, 2023 May 31, 2023Categories AnnouncementsYour daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG
February 10, 2023 February 10, 2023Categories Announcements News StoriesThe January/February 2023 News from ECOG-ACRIN blog is now available
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
October 26, 2022 October 26, 2022Categories Press ReleasesPress Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib
October 13, 2022 October 13, 2022Categories Announcements News StoriesThe September/October 2022 News from ECOG-ACRIN blog is now available
August 16, 2022 August 16, 2022Categories Announcements News StoriesThe August 2022 News from ECOG-ACRIN blog is now available
June 22, 2022 June 22, 2022Categories News StoriesFDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH
